A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma
Abstract Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow‐up imag...
Saved in:
| Main Authors: | Daniel J. Glazar, Solmaz Sahebjam, Hsiang‐Husan M. Yu, Dung‐Tsa Chen, Menal Bhandari, Heiko Enderling |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | CPT: Pharmacometrics & Systems Pharmacology |
| Online Access: | https://doi.org/10.1002/psp4.13290 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEUTRON RADIATION THERAPY IN THE TREATMENT OF RECURRENT HIGH-GRADE GLIOMA
by: M. M. Sarycheva, et al.
Published: (2021-05-01) -
STING is significantly increased in high-grade glioma with high risk of recurrence
by: Meishi Zhong, et al.
Published: (2024-12-01) -
Cognitive impairments in patients with low grade gliomas and high grade gliomas
by: Eliane C. Miotto, et al.
Published: (2011-08-01) -
Cancer Stem Cell Plasticity as Tumor Growth Promoter and Catalyst of Population Collapse
by: Jan Poleszczuk, et al.
Published: (2016-01-01) -
Provider Volume Impacts Neurosurgical Procedure Selection in Older Patients With High‐Grade Glioma
by: Anne S. Reiner, et al.
Published: (2025-04-01)